Concepedia

Beth Anaclerio

BA

Statistics

Publications

6

Citations

255

H-Index

6

Active since

1999

Affiliations

Johnson & Johnson (United States)(Current)

Genomics Institute of the Novartis Research Foundation

Beth Anaclerio is an author at Johnson & Johnson (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1999–2006

6

Publications

6

Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors

David Ellis, Kelli Kuhen, Beth Anaclerio et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 86 citations

, , +9

Design, Synthesis, and Biological Evaluation of Novel Potent and Selective α<sub>v</sub>β<sub>3</sub>/α<sub>v</sub>β<sub>5</sub> Integrin Dual Inhibitors with Improved Bioavailability. Selection of the Molecular Core

Juan Marugán, Carl L. Manthey, Beth Anaclerio et al. · Journal of Medicinal Chemistry · 2005 · 68 citations · Full text

, , +17

Cyclobutane carboxamide inhibitors of fungal melanin: biosynthesis and their evaluation as fungicides

Lee D. Jennings, Dennis R. Rayner, Douglas B. Jordan et al. · Bioorganic & Medicinal Chemistry · 2000 · 36 citations · Full text

, , +5

Non-peptidic αvβ3 antagonists containing indol-1-yl propionic acids

Kristi Leonard, Wenxi Pan, Beth Anaclerio et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 27 citations · Full text

, , +5

Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1

Baogen Wu, Kelli Kuhen, Truc N. Nguyen et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 21 citations · Full text

, , +10

1–5 of 6